Navigation Links
Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
Date:9/2/2007

New approach for treatment of schizophrenia

INDIANAPOLIS, Sept. 2 /PRNewswire-FirstCall/ -- An investigational, phase II study published in the scientific journal Nature Medicine demonstrates that for the first time in humans a drug that acts on certain proteins in the brain called mGlu2/3 has antipsychotic activity. The study was sponsored by Eli Lilly and Company (NYSE: LLY).

In this study - a randomized, double-blind, placebo-controlled clinical trial - patients were assigned to four weeks of treatment with either Lilly's investigational compound LY2140023; olanzapine, an atypical antipsychotic medication that targets dopamine and serotonin receptors as an active control; or placebo. The study demonstrated that:

-- LY2140023 and olanzapine showed statistically significant improvement

versus placebo in PANSS (Positive and Negative Syndrome Scale), the

most common scale used for measuring symptoms of patients with

schizophrenia. Both groups showed a rapid response, within one week.

-- Treatment with LY2140023 was not observed to have certain adverse

events that often occur with currently approved schizophrenia

medications, including increased prolactin elevations, extrapyramidal

symptoms (involuntary movements or muscle stiffness), or weight gain.

-- Overall, LY2140023 40 mg given twice daily was found to be safe and

well-tolerated, with most adverse events being mild-to-moderate in

severity and not treatment-limiting.

"These data provide compelling new evidence that mGlu2/3 receptor agonists have antipsychotic properties and may provide a completely new therapeutic approach for treating schizophren
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. New Drug Application Submitted for Investigational Antibiotic Doripenem
2. Astrazenecas Investigational Cancer Therapies Revealed at ASCO
3. Investigational Drug Being Pursued for the Treatment of Ischaemic Stroke
4. Novel Investigational Drug May Help American Women Suffering from Breast Pain
5. Effective And Economical Agent For Anthrax
6. New target for antidiabetic agents identified
7. Gold Nanoparticles: Agents For Noninvasive Cancer Therapy
8. A potent causative agent of dental flourosis: Fluoride
9. Another causative agent of adult onset asthma : Atopy
10. Revelation Of Cancer Agent Could Help In Developing Effective Cancer Drugs
11. Sunitinib a Promising Agent for Treatment of Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... September 22, 2014 Dry Face Brushing brings ... 3: , 1) Dry Brushing improves blood circulation and tone, ... exfoliates dead cells, toxins and debris from the skin , ... movement , While Body Brushing can and should be done ... it is more fragile and thinner, it needs less. ...
(Date:9/21/2014)... Clara, CA (PRWEB) September 22, 2014 ... conference it has entered into a joint services agreement ... South Dakota, to deploy the CareSpan Virtual Clinic in ... and Avera eCARE plan to deploy their joint services ... Dakota and Wyoming where Avera eCARE is licensed. The ...
(Date:9/21/2014)... birth of an infant prior to 37 weeks of ... increased over the past two decades. According to ... birth affects nearly 500,000 babies each year, or one ... care has improved survival rates for preterm infants, questions ... of preterm infants. , Research led by Barry M. ...
(Date:9/21/2014)... who smoke, those using e-cigarettes (in addition to traditional ... likely to have quit smoking traditional cigarettes than non-users. ... journal of the American Cancer Society, the findings raise ... cancer patients give up smoking. , Because of the ... should be advised to quit. But the rising use ...
(Date:9/21/2014)... 19, 2014) Instituting a partial smoking ban at ... expired carbon monoxide levels, an indicator of exposure to ... residents, health, according to new research. The University of ... study results last week in the journal Addictive ... United States has fallen to 18 percent among adults, ...
Breaking Medicine News(10 mins):Health News:Gorgeous Skin: 3 Top Benefits of Dry Face Brushing from Sublime Beauty® 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 3Health News:Research evaluates neurodevelomental and medical outcomes in single family room NICU 2Health News:Research evaluates neurodevelomental and medical outcomes in single family room NICU 3Health News:E-cigarettes unhelpful in smoking cessation among cancer patients 2Health News:UTHealth researchers study impact of smoking ban in homeless shelter 2
... may help diagnose heart disease, cancers, HIV and other ... clinical methods. The microsponges are an essential component of ... a new paper in the journal Small . ... Professor in Bioengineering and Chemistry, and his colleagues at ...
... the highest adolescent pregnancy and birth rate among developed countries ... pregnant do not have aspirations of going to college or ... researchers at Women & Infants Hospital of Rhode Island shows ... college and get a good job. Whether or not the ...
... Kathleen Doheny HealthDay Reporter , WEDNESDAY, Feb. 9 ... every day may be cutting down on calories, but they ... suggests. "In our study, we saw a significant increased ... regular soda," said Hannah Gardener, an epidemiologist at the University ...
... Louisville School of Medicine professors recently authored reference works ... use of radiation treatment for childhood cancers and the ... Edward C. Halperin, dean of the school, is co-author ... Dr. Kelly M. McMasters, chair of the Department of ...
... the number of brain injuries and deaths from crashes, appear ... spine injury, new research from Johns Hopkins suggests. "We ... riding a motorcycle can be detrimental during a motorcycle crash," ... professor of surgery at the Johns Hopkins University School of ...
... reliance on coastal waters for food, trade and tourism ... closely monitored to guarantee their future sustainability. ESA,s ... full advantage of the unique capabilities of the Medium ... With a resolution of 300 m, MERIS ...
Cached Medicine News:Health News:Microsponges from seaweed may save lives 2Health News:Microsponges from seaweed may save lives 3Health News:Research: Pregnant teens want to go to college, need support 2Health News:Can Diet Soda Boost Your Stroke Risk? 2Health News:Can Diet Soda Boost Your Stroke Risk? 3Health News:New works by UofL professors provide latest oncology reference guides 2Health News:Motorcycle helmets reduce spine injuries after collisions 2Health News:ESA's sharp eyes on coastal waters 2
(Date:9/20/2014)... 2014 /CNW/ - The issue: Mylan Pharmaceuticals ULC Canada, in ... its Mylan-Nitro Spray 0.4 mg/metered dose due to the product ... component. A missing "dip tube" could pose ... patient. This defect may lead patients to believe they are ... access it. Not receiving nitroglycerin could place them at risk ...
(Date:9/19/2014)... HILL, N.C. , Sept. 19, 2014 /PRNewswire/ ... role in forging relationships with key opinion leaders ... market and competition. Despite the critical nature of ... created many challenges, including altering the landscape for ... According to research, the oversight responsibility ...
(Date:9/19/2014)... 2014 Harwood Feffer LLP ( www.hfesq.com ) ... of PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: ... breached its fiduciary duties to shareholders or violated the ... the Company disclosed: "On September 11, 2014, [PDL] was ... & Young LLP ("EY"), that it was resigning effective ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... 21, 2011  TriReme Medical, Inc. ("TriReme"), a leading ... complex vascular disease, announced today that it has ... Drug Administration to market its Chocolate PTA balloon ... arteries. Chocolate was developed in collaboration with TriReme,s ...
... ceremony coinciding with the 20th anniversary of Los Angeles ... acquired HIV, the University at Buffalo,s School of Pharmacy ... WAT ) for its donation of a state-of-the-art ACQUITY® ... used to build laboratory capacity and advance research into ...
Cached Medicine Technology:TriReme Medical, Inc. Receives FDA 510(K) Clearance for Chocolate PTA Balloon Catheter 2Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 2Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 3Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 4
... AquaFlow™ Collagen Glaucoma Drainage Device when ... procedure has been proven to significantly ... the complications often associated with penetrating ... medications. As a result, patient outcomes ...
... Control is a device ... a filter between the ... tubing that captures nuclear ... and efficiency of phaco ...
... is an innovative, stat analyzer that measures ... on-board co-oximetry and integrated data management "all ... include pH, PCO 2 , PO 2 ... sodium, potassium, chloride, ionized calcium, ionized magnesium, ...
... Bio-logic has demonstrated continuous innovations in computerized ... first Digital EEG system brings the latest ... VISION is the first Windows XP Pro ... all your EEG needs: epilepsy monitoring, routine ...
Medicine Products: